Stenotrophomonas maltophilia in lower respiratory tract infections

Journal of Clinical and Diagnostic Research

Volumn 8, Issue 12, 2014, Pages DC20-DC22

  Chawla, Kiran ^a   Vishwanath, Shashidhar ^a   Gupta, Ashu ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Antimicrobial drug resistance; Quinolones; Stenotrophomonasmaltophilia; Trimethoprim sulfamethoxazole

Indexed keywords

COTRIMOXAZOLE; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER; ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COMORBIDITY; DISK DIFFUSION; FEMALE; GENDER; HEMATOTHORAX; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; MALE; MEDICAL RECORD; MICROBIOLOGICAL EXAMINATION; MORTALITY; PNEUMONIA; PNEUMOTHORAX; PSEUDOMONAS AERUGINOSA; RADIODIAGNOSIS; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; TERTIARY CARE CENTER; THORAX RADIOGRAPHY; TRACHEAL ASPIRATION PROCEDURE; TREATMENT OUTCOME; VERY ELDERLY;

STENOTROPHOMONAS MALTOPHILIA;

EID: 84919394643     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2014/10780.5320     Document Type: Article

References (13)

1. Looney WJ, Narita M, Muhlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet infect Dis. 2009;9:312-23.
2. Sanyal SC, Mokaddas EM. The increase in carbapenems use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen. J Chemother. 1999;11:28-33.
3. Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston K. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother. 1994; 38:624.
4. Falagas ME, Valkimadi PE, Huang YT, Matthaiou DK, Hsueh PR. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother. 2008;62:889-94.
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twenty-third informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA, 2013.
6. Betriu C, Sánchez A, Palau ML, Gómez M, Picazo JJ. Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993-1999. J Antimicrob Chemother. 2001;48:152-54.
7. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev. 1998;11:57-80.
8. Neela V, Rankouhi SZR, van Belakum A, Goering RV and Awang R. Stenotrophomonas maltophilia in Malaysia: Molecular epidemiology and trimethoprim-sulphamethoxazole resistance. Inter J Infec Dis. 2012;16:e603-7.
9. Tsang WaiKan Kassel, Lee Kalok Ryan and Allen Li. Computed tomography features of Stenotrophomonas maltophilia pneumonia in patients with neutropenic fever: report of two cases. Multidiscip Respir Med. 2013;8:14.
10. Gautam V, Ray P, Vandamme P, Chatterjee S, Das A, Sharma K, et al. Identification of lysine positive non-fermenting gram negative bacilli (Stenotrophomonas maltophilia and Burkholderia cepacia complex). Indian J Med Microbiol. 2009;27 (2):128-33.
11. Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25:2-41.
12. Toleman MA, Bennett PM, Bennett DMC, Jones RN, Walsh TR. Global Emergence of Trimethoprim/Sulfamethoxazole Resistance in Stenotrophomonas maltophilia mediated by acquisition of sul Genes. Emerg Infect Dis. 2007;13:559-65.
13. Kwa ALH, Low JGH, Lim TP, Leow PC, Kurup A, Tam VH. Independent Predictors for Mortality in Patients with Positive Stenotrophomonas maltophilia Cultures. Ann Acad Med Singapore. 2008;37:826-30.